Form 8-K - Current report:
SEC Accession No. 0001828185-24-000083
Filing Date
2024-11-06
Accepted
2024-11-06 08:04:49
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brns-20241106.htm   iXBRL 8-K 27256
2 EX-99.1 brns-20240930xexx991.htm EX-99.1 161715
7 a1.jpg GRAPHIC 5260
  Complete submission text file 0001828185-24-000083.txt   388184

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20241106.xsd EX-101.SCH 2640
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20241106_def.xml EX-101.DEF 16922
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20241106_lab.xml EX-101.LAB 29996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20241106_pre.xml EX-101.PRE 17774
19 EXTRACTED XBRL INSTANCE DOCUMENT brns-20241106_htm.xml XML 4246
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 241429305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)